-
Document issued by Hebei health and Health Commission: "four medical linkage" comprehensive control of drug costs
Time of Update: 2020-06-19
Medical network, May 26 - recently, Hebei health and Health Commission issued the notice of the leading group of deepening the reform of medical and health system of Hebei Province on printing and Dis
-
FDA has awarded the first three co-discovery of the new drug quizartinib breakthrough therapy
Time of Update: 2020-06-11
AML is a malignant blood and bone marrow cancer that causes abnormally dysfunctional cancerous white blood cells in the patient's body to grow and accumulate uncontrolledly and affect the production
-
Sci Rep: Targeted therapy significantly inhibits breast cancer tumor growth in mice
Time of Update: 2020-06-05
June 2, 2020 /PRNewswire BIOON/ -- A team of researchers led by Wole Soboyejo, dean of the Worcester Institute of Technology (WPI), has identified a targeted drug that can reduce the size of in h
-
Professor Wang Xiaojia: More affordable, Sidabenamine offers breast cancer patients more treatment options
Time of Update: 2020-05-29
On April 10, 2020, the 2020 edition of the Chinese Society of Clinical Oncology (CSCO) Breast Cancer Diagnostic Guidelines was released in a new way through "cloud" remote video conferencing In thi
-
China's milestone development releases global dividend
Time of Update: 2020-03-02
Recently, China's economic "report card" for 2019 issued by the National Bureau of statistics of the people's Republic of China is full of bright spots, especially when the per capita gross domestic p
-
Sichuan: price and supply of four kinds of drugs will be monitored
Time of Update: 2019-12-31
On December 30, Sichuan Medical equipment bidding and purchasing service center put up the notice on the investigation of the production cost of drugs with abnormal price changes (hereinafter referred
-
40 kinds of special preparations for children have been included in the list of primary hospitals, making it more convenient for citizens to buy drugs
Time of Update: 2019-12-04
[pharmaceutical network industry trends] recently, Jiangsu Provincial Health Commission and Drug Administration issued a notice on the list of special preparations for children and the list of transfe
-
Policy · solution · 4+7 purchase with quantity leads to "Butterfly Effect" medical insurance negotiation bargain
Time of Update: 2019-12-02
Original: Linan In this month, volume purchasing is still the focus of the industry The state has made great efforts to promote a new round of centralized purchase At the time when the State Council i
-
Notice on adjusting the price of some drugs
Time of Update: 2019-09-20
On the afternoon of 18 th, the Jiangsu announcement resource trading network announced the notice on adjusting the price of some pharmaceutical supplies According to the application of enterprises, th
-
Prediction of the list of products to be negotiated in 2019 national medical insurance catalogue
Time of Update: 2019-08-28
One week after the release of 2019 national health insurance catalog, the noise brought by various data analysis and comment articles gradually calmed down The biggest egg should be the list of 128 ne
-
New product: Zhengda Tianqing abitrone acetate tablet approved for market
Time of Update: 2019-07-18
Recently, the application for listing of Zhengda Tianqing abitrone acetate tablets (qingkeshu) was approved by the State Drug Administration Abiterone acetate combined therapy has been designated as t
-
44 enterprises failed to supply drugs according to regulations, and 11 were further investigated
Time of Update: 2019-07-03
Yesterday, Liaoning Province released the notice on the investigation of drugs not supplied according to the agreed price and regulations reported by medical and health institutions in May 2019, which
-
Liaoning Province publishes the process and catalogue of dynamic adjustment of joint price negotiation for centralized drug purchase
Time of Update: 2019-05-31
Yesterday, the drug centralized purchase platform of Liaoning Province announced the notice of dynamic adjustment of joint price negotiation for drug centralized purchase of medical institutions in 20
-
Mol bio cell: environmental pressure mediated gene mutation leads to drug resistance of cancer cells
Time of Update: 2019-02-24
February 24, 2019 / BIOON / - how cells obtain gene mutations is a very basic biological problem Research on this problem has an impact on many areas of biomedical research (from tumor evolution to ce
-
Kanamycin of Lizhu pharmaceutical has passed the PQ certification of who and entered the international market
Time of Update: 2019-02-15
Today (February 15) Lizhu pharmaceutical announced that its wholly-owned subsidiary Lizhu group Lizhu pharmaceutical factory has received the PQ (pre certification) confirmation letter issued by the W
